(Q39645892)

13 September 2017

title

Inhibition of ErbB2 by herceptin reduces viability and survival, induces apoptosis and oxidative stress in Calu-3 cell line (English)

1 reference

13 September 2017

Inhibition of ErbB2 by Herceptin reduces viability and survival, induces apoptosis and oxidative stress in Calu-3 cell line (English)

1 reference

https://api.crossref.org/works/10.1007/S11010-010-0610-7

30 July 2024

author name string

Irem Dogan

1

1 reference

13 September 2017

Ahmet Cumaoglu

2

1 reference

13 September 2017

Aysel Aricioglu

3

1 reference

13 September 2017

Abdullah Ekmekci

4

1 reference

13 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20936496

30 July 2024

publication date

10 October 2010

1 reference

full work available at URL

13 September 2017

http://link.springer.com/content/pdf/10.1007/s11010-010-0610-7.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S11010-010-0610-7

http://link.springer.com/article/10.1007/s11010-010-0610-7/fulltext.html

30 July 2024

1 reference

https://api.crossref.org/works/10.1007/S11010-010-0610-7

http://link.springer.com/content/pdf/10.1007/s11010-010-0610-7

30 July 2024

1 reference

https://api.crossref.org/works/10.1007/S11010-010-0610-7

Molecular and Cellular Biochemistry

30 July 2024

published in

1 reference

13 September 2017

volume

347

1 reference

13 September 2017

issue

1-2

1 reference

13 September 2017

page(s)

41-51

1 reference

The importance of oxidative stress in apoptosis

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0610-7

Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts

21 January 2018

1 reference

12 December 2020

Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical.

1 reference

12 December 2020

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

1 reference

12 December 2020

Signal transduction and oncogenesis by ErbB/HER receptors

1 reference

12 December 2020

A simple method for clinical assay of superoxide dismutase

1 reference

12 December 2020

Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer

1 reference

12 December 2020

Complex cellular responses to reactive oxygen species

1 reference

12 December 2020

Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer

1 reference

12 December 2020

Inhibition of ErbB2 by Herceptin reduces survivin expression via the ErbB2-beta-catenin/TCF4-survivin pathway in ErbB2-overexpressed breast cancer cells

1 reference

12 December 2020

The biology of erbB-2/neu/HER-2 and its role in cancer

1 reference

12 December 2020

Synergistic interaction between trastuzumab and EGFR/HER-2 tyrosine kinase inhibitors in HER-2 positive breast cancer cells

1 reference

12 December 2020

Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action

1 reference

12 December 2020

Herceptin-induced inhibition of ErbB2 signaling involves reduced phosphorylation of Akt but not endocytic down-regulation of ErbB2.

1 reference

12 December 2020

Herceptin sensitizes ErbB2-overexpressing cells to apoptosis by reducing antiapoptotic Mcl-1 expression

1 reference

12 December 2020

Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization

1 reference

12 December 2020

1 reference

12 December 2020

Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer

1 reference

12 December 2020

Pathology of lung cancer

1 reference

12 December 2020

Is EGFR expression important in non-small cell lung cancer?

1 reference

12 December 2020

Expression of the NF-κB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively

1 reference

12 December 2020

The type I growth factor receptors in human breast cancer

1 reference

12 December 2020

Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs

1 reference

12 December 2020

Inhibition of ErbB2/neuregulin signaling augments paclitaxel-induced cardiotoxicity in adult ventricular myocytes

1 reference

12 December 2020

Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells

1 reference

12 December 2020

Dihydrorhodamine 123: a fluorescent probe for superoxide generation?

1 reference

12 December 2020

A simple technique for quantifying apoptosis in 96-well plates

1 reference

12 December 2020

HER2 overexpression and cancer targeting

1 reference

12 December 2020

Inhibition of functional HER family members increases the sensitivity to docetaxel in human ovarian cancer cell lines

1 reference

12 December 2020

A specific vascular endothelial growth factor receptor tyrosine kinase inhibitor enhances the antiproliferative effect of trastuzumab in human epidermal growth factor receptor 2 overexpressing breast cancer cell lines

1 reference

12 December 2020

ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer

1 reference

12 December 2020

A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.

1 reference

12 December 2020

Correlation between encoded protein overexpression and copy number of the HER2 gene with survival in non-small cell lung cancer

1 reference

12 December 2020

Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expression

1 reference

12 December 2020

Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane

1 reference

12 December 2020

Regulation of survivin by ErbB2 signaling: therapeutic implications for ErbB2-overexpressing breast cancers

1 reference

12 December 2020

Cancer statistics, 2008

1 reference

12 December 2020

Oxidative stress responses of the yeast Saccharomyces cerevisiae

1 reference

12 December 2020

Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung

1 reference

12 December 2020

HER2 therapy: molecular mechanisms of trastuzumab resistance.

1 reference

12 December 2020

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

1 reference

12 December 2020

Targeted therapy for targeted patients: trastuzumab in adjuvant treatment of non-small-cell lung cancer

1 reference

12 December 2020

Survivin gene expression in early-stage non-small cell lung cancer.

1 reference

12 December 2020

Nuclear factor-kappaB: the enemy within

1 reference

12 December 2020

Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis.

1 reference

12 December 2020

An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7

1 reference

12 December 2020

Expression of ErbB2 enhances radiation-induced NF-kappaB activation

1 reference

12 December 2020

Determination of glutathione and glutathione disulfide in biological samples

1 reference

12 December 2020

Her2-targeted therapies in non-small cell lung cancer

1 reference

12 December 2020

Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents

1 reference

12 December 2020

The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand.

1 reference

12 December 2020

Cardiac toxicity with anti-HER-2 therapies: what have we learned so far?

1 reference

12 December 2020

Mechanisms of resistance to HER family targeting antibodies

1 reference

12 December 2020

Trastuzumab in the treatment of advanced non-small-cell lung cancer: is there a role?

1 reference

12 December 2020

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

1 reference

12 December 2020

Nuclear factor-κB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas

1 reference

12 December 2020

Validating survivin as a cancer therapeutic target

1 reference

12 December 2020

Biochimica et Biophysica Acta

11

1198

165

NE Hynes

1994

1 reference

https://api.crossref.org/works/10.1007/S11010-010-0610-7

30 July 2024

Identifiers

1 reference

13 September 2017

1 reference